China Pharma Holdings (CPHI) Assets (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Assets came in at $45.1 million in Q1 2026, up 217.53% YoY from $14.2 million in Q1 2025, and up 45.63% on a QoQ basis from $31.0 million in Q4 2025.
China Pharma Holdings (CPHI) Assets (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Assets data on file, last reported at $45.1 million in Q1 2026.
- Quarterly Assets rose 217.53% year-over-year to $45.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $45.1 million (up 217.53% YoY) and the FY2025 annual result came in at $31.0 million, up 108.22% from the prior year.
- Assets advanced to $45.1 million in Q1 2026, from $31.0 million in the prior quarter.
- In the past five years, Assets ranged from a high of $45.1 million in Q1 2026 to a low of $13.5 million in Q3 2024.
- A 5-year average of $18.6 million and a median of $16.2 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2022 — Assets slipped 21.48% — and 2026, when it soared 217.53%.
- Tracing CPHI's Assets over 5 years: stood at $17.8 million in 2022, then declined by 7.39% to $16.5 million in 2023, then decreased by 9.6% to $14.9 million in 2024, then soared by 108.22% to $31.0 million in 2025, then soared by 45.63% to $45.1 million in 2026.
- The last three Assets figures came in at $45.1 million (Q1 2026), $31.0 million (Q4 2025), and $15.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.71 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.86 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 15.08 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.27 Bn |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 7.22 Bn |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 35.04 Bn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 5.36 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.56 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 6.18 Bn |
| 10 | China Pharma Holdings | 42.70 Mn | 42.39 Mn | 83,566.00 | 44.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.14 Mn |
| Dec 31, 2025 | 31.00 Mn |
| Sep 30, 2025 | 15.80 Mn |
| Jun 30, 2025 | 13.77 Mn |
| Mar 31, 2025 | 14.22 Mn |
| Dec 31, 2024 | 14.89 Mn |
| Sep 30, 2024 | 13.47 Mn |
| Jun 30, 2024 | 14.26 Mn |
| Mar 31, 2024 | 16.19 Mn |
| Dec 31, 2023 | 16.47 Mn |
| Sep 30, 2023 | 15.35 Mn |
| Jun 30, 2023 | 15.70 Mn |
| Mar 31, 2023 | 17.36 Mn |
| Dec 31, 2022 | 17.78 Mn |
| Sep 30, 2022 | 16.20 Mn |
| Jun 30, 2022 | 17.92 Mn |
| Mar 31, 2022 | 21.04 Mn |
| Dec 31, 2021 | 22.65 Mn |
| Sep 30, 2021 | 18.18 Mn |
| Jun 30, 2021 | 19.94 Mn |